Screening and early diagnosis are recommended within hereditary syndromes, given the evidence supporting the correlation between increased ovarian cancer risk and hereditary genetic mutations, primarily represented by BRCA1-2, homologous recombination gene panel germline mutations, and Lynch syndrome. This evidence concerns the gene BRCA1 and ovarian carcinoma.